Skip to main content
OpenTrials

Clinical trial condition

Adenocarcinoma Of Esophagus

Explore clinical trials studying Adenocarcinoma Of Esophagus. Study availability and eligibility vary by location and protocol.

254 public trials 62 recruiting studies
Refine in advanced search Browse all conditions

Adenocarcinoma Of Esophagus trial results

Active, Not Recruiting

A Study of Zanidatamab in Combination With Chemotherapy Plus or Minus Tislelizumab in Patients With HER2-positive Advanced or Metastatic Gastric and Esophageal Cancers

NCT05152147

Conditions
Adenocarcinoma Of Esophagus, Digestive System Diseases, Digestive System Neoplasms, +13 more
Locations
  • Hospital de Gastroenterología Dr Bonorino Udaondo Buenos Aires, Argentina
  • Instituto de Investigaciones Metabólicas - IDIM Buenos Aires, Argentina
  • Hospital Italiano de Buenos Aires Buenos Aires, Argentina
  • Fundación Centro de Medicina Nuclear y Molecular ER Córdoba, Argentina
View all 227 locations
View Trial Details
Active, Not Recruiting

Testing the Addition of Radiotherapy to the Usual Treatment (Chemotherapy) for Patients With Esophageal and Gastric Cancer That Has Spread to a Limited Number of Other Places in the Body

NCT04248452

Conditions
Adenocarcinoma Of Esophagus, Clinical Stage IV Esophageal Adenocarcinoma AJCC v8, Clinical Stage IV Gastric Cancer AJCC v8, +12 more
Locations
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
  • Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
View all 453 locations
View Trial Details
Active, Not Recruiting

Paclitaxel With or Without Cixutumumab as Second-Line Therapy in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer

NCT01142388

Conditions
Adenocarcinoma Of Esophagus, Carcinoma, Carcinoma, Squamous Cell, +21 more
Locations
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • Stanford Cancer Institute Palo Alto Palo Alto, California, United States
  • The Medical Center of Aurora Aurora, Colorado, United States
  • Boulder Community Foothills Hospital Boulder, Colorado, United States
View all 232 locations
View Trial Details
Active, Not Recruiting

A Study to Evaluate ARV-806 in Adults With Advanced Cancer That Has the KRAS G12D Mutation

NCT07023731

Conditions
Adenocarcinoma, Adenocarcinoma Of Esophagus, Adnexal Diseases, +61 more
Locations
  • Clinical Trial Site Phoenix, Arizona, United States
  • Clinical Trial Site Phoenix, Arizona, United States
  • Clinical Trial Site New Haven, Connecticut, United States
  • Clinical Trial Site Tampa, Florida, United States
View all 14 locations
View Trial Details
Active, Not Recruiting

A Safety and Efficacy Study of Treatment Combinations With and Without Chemotherapy in Adult Participants With Advanced Upper Gastrointestinal Tract Malignancies

NCT05329766

Conditions
Adenocarcinoma Of Esophagus, Digestive System Diseases, Digestive System Neoplasms, +7 more
Locations
  • Research Site Phoenix, Arizona, United States
  • Research Site Los Angeles, California, United States
  • Research Site Santa Monica, California, United States
  • Research Site Derby, Connecticut, United States
View all 43 locations
View Trial Details
Active, Not Recruiting

Testing the Addition of an Anti-cancer Drug, Adavosertib, to Radiation Therapy for Patients With Incurable Esophageal and Gastroesophageal Junction Cancers

NCT04460937

Conditions
Adenocarcinoma Of Esophagus, Brain Diseases, Brain Neoplasms, +80 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • Northwestern University Chicago, Illinois, United States
  • University of Kentucky/Markey Cancer Center Lexington, Kentucky, United States
  • Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
View Trial Details
Active, Not Recruiting

Aspirin in Preventing Disease Recurrence in Patients With Barrett Esophagus After Successful Elimination by Radiofrequency Ablation

NCT02521285

Conditions
Adenocarcinoma Of Esophagus, Barrett Esophagus, Digestive System Diseases, +5 more
Locations
  • UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States
  • UCHealth University of Colorado Hospital Aurora, Colorado, United States
  • Northwestern University Chicago, Illinois, United States
  • Mayo Clinic in Rochester Rochester, Minnesota, United States
View Trial Details
Active, Not Recruiting

A Study of agenT-797 in Combination With Botensilimab, Balstilimab, Ramucirumab, and Paclitaxel for People With Esophageal, Gastric, or Gastro-esophageal Junction Cancer

NCT06251973

Conditions
Adenocarcinoma Of Esophagus, Advanced Unresectable Gastric Adenocarcinoma, Digestive System Diseases, +22 more
Locations
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Suffolk-Commack (Limited protocol activities) Commack, New York, United States
View Trial Details

Related conditions